Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2,Double Blind Randomized Study of PraevoSkin,a Melatonin Containing Emulsion, in the Prevention of Radiation Induced Dermatitis.

NCT00840515 is registered in ClinicalTrials.gov with Pharm Olam Pharmaceuticals Ltd. as lead sponsor.

NCT NCT00840515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00840515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2,Double Blind Randomized Study of PraevoSkin,a Melatonin Containing Emulsion, in the Prevention of Radiation Induced Dermatitis.
Lead sponsor
Pharm Olam Pharmaceuticals Ltd.
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2009
Completion date
August 31, 2009
Enrollment
1 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prevention of radiation induced dermatitis.